Hydroxyurea treatment for adult sickle cell anemia patients in Kinshasa

Hydroxyurea treatment for adult sickle cell anemia patients in Kinshasa

Abstract Background: Despite a high incidence of sickle cell anemia, hydroxyurea (HU) treatment is rarely used in the DR Congo. This study aims to assess the efficacy of HU, the incidence of side effects that may limit its use in adults and to determine the dose needed for clinical improvement in pa...

Full description

Bibliographic Details
Main Authors: Paul Lumbala Kabuyi, Gloire Mbayabo, Mamy Ngole, Aimé Lumaka Zola, Valerie Race, Gert Matthijs, Chris Van Geet, Prosper Lukusa Tshilobo, Koenraad Devriendt, Tite Minga Mikobi
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:eJHaem
Subjects:
adult patients
hydroxyurea
Kinshasa
sickle cell anemia
Online Access:https://doi.org/10.1002/jha2.735

Similar Items

Similar Items